Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letibotulinum toxin A for melasma: two different dilutions in a randomized double-blind split-face study
TCTR20250208002Phase 3Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Jun 2023
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of letibotulinumtoxinA in melasma, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Jun 2023; status: completed.
02
Drugs
letibotulinumtoxinA
03
Conditions
melasma
Beyond the preview
Go deeper on TCTR20250208002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250208002.